Exploring the Use of Complementary and Alternative Medicine in Cancer Patients.
cancer
complementary and alternative medicine
contributing factors
cultural-related factors
disease-related factors
gender differences
socioeconomic factors
Journal
Integrative cancer therapies
ISSN: 1552-695X
Titre abrégé: Integr Cancer Ther
Pays: United States
ID NLM: 101128834
Informations de publication
Date de publication:
Historique:
entrez:
11
5
2019
pubmed:
11
5
2019
medline:
18
12
2019
Statut:
ppublish
Résumé
In Australia, it is estimated that around 17% to 87% of cancer patients have used one form of complementary therapy during their cancer treatment. There are numerous reasons and contributing factors for cancer patients to consider using complementary and alternative medicine (CAM). CAM information and products are readily available. However, the level of evidence to support the benefits of use in the cancer setting is limited, and the associated adverse effects and interactions with conventional medicine may not be fully studied. Besides, not all health professionals favor the concept of integrative health approaches, or have the confidence in dealing with CAM due to a lack of knowledge and standardization of practices. A thematic review of the literature was performed on the main contributing factors to cancer patients' use of CAM, as well as the current issues that may be encountered by the patients and health professionals.
Identifiants
pubmed: 31072149
doi: 10.1177/1534735419846986
pmc: PMC7242794
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1534735419846986Références
Breast. 2008 Aug;17(4):387-94
pubmed: 18534852
Cancer. 1998 Aug 15;83(4):777-82
pubmed: 9708945
Int J Clin Pract. 2010 Sep;64(10):1350-8
pubmed: 20716143
Med Princ Pract. 2017;26(1):41-49
pubmed: 27607437
Int J Clin Pract. 2012 Oct;66(10):924-39
pubmed: 22994327
Br J Cancer. 2004 Jan 26;90(2):408-13
pubmed: 14735185
J Natl Cancer Inst Monogr. 2014 Nov;2014(50):346-58
pubmed: 25749602
Br J Clin Psychol. 1996 Feb;35(1):37-48
pubmed: 8673034
Cancer J. 2006 Nov-Dec;12(6):467-74
pubmed: 17207316
Support Care Cancer. 2001 Jun;9(4):267-74
pubmed: 11430423
Complement Ther Clin Pract. 2016 May;23:34-9
pubmed: 27157956
Integr Cancer Ther. 2012 Sep;11(3):232-42
pubmed: 22313741
Cancer. 2015 Jul 15;121(14):2431-8
pubmed: 26011157
N Engl J Med. 1999 Jun 3;340(22):1733-9
pubmed: 10352166
Support Care Cancer. 2011 Jan;19(1):67-80
pubmed: 19943067
Adv Data. 2004 May 27;(343):1-19
pubmed: 15188733
Integr Cancer Ther. 2015 Jul;14(4):350-8
pubmed: 25873293
Gerontology. 2007;53(1):21-7
pubmed: 16960457
Nurs Res. 2010 Jan-Feb;59(1):58-66
pubmed: 20010046
BMC Complement Altern Med. 2016 Oct 29;16(1):425
pubmed: 27793133
Urology. 2005 Dec;66(6):1223-8
pubmed: 16360447
Int J Cancer. 2008 Sep 15;123(6):1227-39
pubmed: 18623084
Ann Oncol. 2005 Apr;16(4):655-63
pubmed: 15699021
Integr Cancer Ther. 2015 Nov;14(6):515-24
pubmed: 26069277
Oncologist. 2006 Jul-Aug;11(7):732-41
pubmed: 16880232
Patient Educ Couns. 2012 Dec;89(3):529-36
pubmed: 22464017
BMC Complement Altern Med. 2016 Jun 11;16:176
pubmed: 27289517
Acad Med. 2001 Mar;76(3):230-7
pubmed: 11242572
Ann Palliat Med. 2014 Jul;3(3):203-28
pubmed: 25841696
Aust Fam Physician. 2017;46(5):316-320
pubmed: 28472578
J Altern Complement Med. 2007 Jul-Aug;13(6):643-50
pubmed: 17718647
Aust Fam Physician. 2010 Sep;39(9):671-4
pubmed: 20877774
J Glob Oncol. 2018 Sep;4:1-6
pubmed: 30241173
Soc Sci Med. 2003 Feb;56(4):851-62
pubmed: 12560017
Asia Pac J Clin Oncol. 2014 Dec;10(4):289-96
pubmed: 25244342
Support Care Cancer. 1998 Jul;6(4):337-47
pubmed: 9695201
J Altern Complement Med. 2009 May;15(5):545-50
pubmed: 19422284
J Cancer Surviv. 2011 Mar;5(1):8-17
pubmed: 20924711
Scand J Public Health. 2018 Jun;46(4):448-455
pubmed: 28975853
Lancet. 1996 Mar 2;347(9001):569-73
pubmed: 8596318
Eur J Cancer Care (Engl). 2006 Sep;15(4):362-8
pubmed: 16968318
Clin J Oncol Nurs. 2010 Jun;14(3):365-70
pubmed: 20529798
BMC Complement Altern Med. 2018 Mar 12;18(1):88
pubmed: 29530034
Health Promot Int. 2009 Sep;24(3):252-61
pubmed: 19531559
Ann Oncol. 2012 Jun;23(6):1571-8
pubmed: 22056972
Ethn Dis. 2008 Winter;18(1):65-71
pubmed: 18447102
Eur J Oncol Nurs. 2012 Dec;16(5):520-7
pubmed: 22330059
Evid Based Complement Alternat Med. 2012;2012:670408
pubmed: 22474513
JAMA. 1998 Nov 11;280(18):1618-9
pubmed: 9820267
Int Semin Surg Oncol. 2007 Apr 30;4:10
pubmed: 17470282
J Palliat Med. 2008 Jan-Feb;11(1):58-67
pubmed: 18370894
Integr Cancer Ther. 2012 Sep;11(3):187-203
pubmed: 22019489
J Complement Integr Med. 2014 Jun;11(2):139-45
pubmed: 24698828
Soc Sci Med. 1975 Feb;9(2):57-62
pubmed: 1093257
J Health Serv Res Policy. 2010 Apr;15 Suppl 2:54-61
pubmed: 20194431
J Adv Nurs. 2005 Mar;49(6):616-23
pubmed: 15737222
J Health Care Poor Underserved. 2011 Feb;22(1):296-310
pubmed: 21317523
JAMA. 1998 May 20;279(19):1548-53
pubmed: 9605899
Complement Ther Med. 2012 Feb-Apr;20(1-2):61-9
pubmed: 22305250
JAMA. 2000 Sep 13;284(10):1290-6
pubmed: 10979117
J Psychosom Res. 1999 Dec;47(6):555-67
pubmed: 10661603
Asia Pac J Clin Oncol. 2014 Mar;10(1):22-37
pubmed: 24571058
Ann Oncol. 2009 Apr;20(4):752-7
pubmed: 19150956
Oncologist. 2006 Jul-Aug;11(7):742-52
pubmed: 16880233
Oncologist. 2012;17(5):607-12
pubmed: 22531358
Patient Educ Couns. 2012 Dec;89(3):489-500
pubmed: 22683293
Evid Based Complement Alternat Med. 2010 Mar;7(1):11-28
pubmed: 18955327
Am J Public Health. 2002 Oct;92(10):1582-91
pubmed: 12356597
BMJ. 1999 Sep 11;319(7211):693-6
pubmed: 10480829
J Psychosom Res. 1990;34(5):525-34
pubmed: 2231486
Cancer Nurs. 1995 Apr;18(2):104-17
pubmed: 7720049
Open Med. 2014 Apr 15;8(2):e54-66
pubmed: 25009685
Support Care Cancer. 2005 Oct;13(10):806-11
pubmed: 15711946
J Public Health (Oxf). 2004 Jun;26(2):152-7
pubmed: 15284318
J Fam Pract. 2000 Feb;49(2):147-52
pubmed: 10718692
Cancer Treat Rev. 2007 Aug;33(5):407-18
pubmed: 17367938
Explore (NY). 2010 Nov-Dec;6(6):380-8
pubmed: 21040887
Med J Aust. 2006 Jan 16;184(2):81-3
pubmed: 16411874
J Health Serv Res Policy. 2011 Apr;16(2):108-17
pubmed: 20819913
J Natl Cancer Inst. 2000 Jan 5;92(1):42-7
pubmed: 10620632
J Altern Complement Med. 2014 Nov;20(11):853-9
pubmed: 25343303
BMJ. 2005 Apr 30;330(7498):1007-11
pubmed: 15860828
Support Care Cancer. 2007 Aug;15(8):973-83
pubmed: 17609997
J Soc Integr Oncol. 2009 Summer;7(3):85-120
pubmed: 19706235
J Clin Oncol. 2000 Jul;18(13):2505-14
pubmed: 10893280
Med J Aust. 2003 Sep 15;179(6):297-300
pubmed: 12964912
Med Decis Making. 2003 Nov-Dec;23(6):471-9
pubmed: 14672107
Int J Clin Pract. 2010 Oct;64(11):1496-1502
pubmed: 20698902
Altern Ther Health Med. 2004 Sep-Oct;10(5):58-64
pubmed: 15478787
J Oncol Pract. 2013 Jan;9(1):34-41
pubmed: 23633969
Asia Pac J Clin Oncol. 2010 Dec;6(4):342-9
pubmed: 21114784
P R Health Sci J. 2008 Mar;27(1):7-19
pubmed: 18450228
Oncologist. 2012;17(11):1475-81
pubmed: 22933591
J Perianesth Nurs. 2011 Oct;26(5):331-7
pubmed: 21939886
J Support Oncol. 2013 Sep;11(3):105-13
pubmed: 24400390
JAMA Oncol. 2016 Sep 1;2(9):1170-6
pubmed: 27243607
J Palliat Med. 2005 Oct;8(5):953-61
pubmed: 16238508